Clinical Next-Generation Sequencing (NSG) Testing Market Growth: Share, Value, Size, Scope, and Insights
Global Clinical Next-Generation Sequencing (NSG) Testing Market, By Technology (Sequencing By Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-time Sequencing, Nano Pore Sequencing and Other Sequencing Technologies), Application (Diagnostics, Drug Discovery, Agricultural and Animal Research and Other Applications), End User (Academic Institutes and Research Centres, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies and Other End Users), Service (Human Genome Sequencing, Single Cell Sequencing, Microbial Genome-based Sequencing, Gene Regulation Services, Animal and Plant Sequencing and Other Sequencing Services), Workflow (Pre-Sequencing, Sequencing and Data Analysis), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
The Clinical Next-Generation Sequencing (NSG) Testing Market sector is expected to undergo significant evolution, with substantial growth and advancements anticipated by 2031. An in-depth analysis of market size, share, and trends is provided through comprehensive market research, offering crucial insights into its expansion. Market segmentation and definitions are explored, with key components and drivers being highlighted. A SWOT analysis gives you a better insight into your internal and external business environment. However, it does not always prioritise the results, which can lead to an improper strategic action
Clinical Next-Generation Sequencing (NSG) Testing Market Industry Trends and Forecast to 2031
What are the projected market size and growth rate of the Clinical Next-Generation Sequencing (NSG) Testing Market?
Technological advancements in the clinical next-generation sequencing (NSG) testing coupled with rising research and development proficiencies are fostering the market growth. Data Bridge Market Research analyses that the clinical next-generation sequencing (NSG) testing market will exhibit a CAGR of around 27.25% for the forecast period of 2021-2028.
Get a Sample PDF of Report - databridgemarketresearch.com/request-a-samp..
Which are the top companies operating in the Clinical Next-Generation Sequencing (NSG) Testing Market?
The report profiles noticeable organizations working in the water purifier showcase and the triumphant methodologies received by them. It likewise reveals insights about the share held by each organization and their contribution to the Clinical Next-Generation Sequencing (NSG) Testing Market extension. This Clinical Next-Generation Sequencing (NSG) Testing Market report provides the information of the Top 10 Companies in Clinical Next-Generation Sequencing (NSG) Testing Market in the market their business strategy, financial situation etc.
Global Clinical Next-Generation Sequencing (NSG) Testing Market Analysis 2020
The global clinical next-generation sequencing (NSG) testing market in 2020 witnessed significant growth as a result of increasing prevalence of chronic diseases, advancements in sequencing technologies, and rising demand for personalized medicine. With the ongoing COVID-19 pandemic, there was also a surge in demand for NGS testing for diagnosis and research purposes. The market was segmented based on technology, application, end-user, and region:
- Technology
- Sequencing by Synthesis (SBS)
- Ion Semiconductor Sequencing
- Single-Molecule Real-Time Sequencing (SMRT)
- Nanopore Sequencing
- Others
- Application
- Oncology
- Reproductive Health
- Clinical Investigation
- Infectious Disease
- Others
- End-User
- Hospitals & Clinics
- Research Institutes
- Diagnostic Laboratories
The market players in the global clinical next-generation sequencing (NSG) testing market in 2020 were key industry participants driving the growth and innovation in the market. Some of the prominent market players included:
- Market Players
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Oxford Nanopore Technologies
- PerkinElmer, Inc.
- Pacific Biosciences of California, Inc.
- Roche Diagnostics
- Qiagen
- Agilent Technologies
- BGI Group
- Myriad Genetics, Inc.
These market players were focused on strategic initiatives such as partnerships, collaborations, product launches, and acquisitions to strengthen their market position and expand their product offerings in the clinical NGS testing market.
The global clinical next-generation sequencing (NGS) testing market is poised for continued growth and innovation in the coming years. One key trend that is expected to shape the market is the increasing adoption of NGS testing in emerging markets. As healthcare infrastructure improves in regions such as Asia-Pacific and Latin America, there is a growing demand for advanced diagnostic tools like NGS testing to address the rising burden of chronic diseases. Market players are likely to focus on expanding their presence in these regions through partnerships and collaborations with local healthcare providers and institutions.
Another important factor driving the growth of the clinical NGS testing market is the rapid advancements in sequencing technologies. Companies such as Illumina, Thermo Fisher Scientific, and Oxford Nanopore Technologies are investing heavily in research and development to enhance the performance and efficiency of NGS platforms. The introduction of novel sequencing technologies like single-molecule real-time sequencing (SMRT) and nanopore sequencing is expected to further accelerate the adoption of NGS testing in clinical settings.
Moreover, the shift towards precision medicine is expected to drive the demand for NGS testing in oncology and other therapeutic areas. As healthcare providers increasingly recognize the value of personalized treatments based on genetic profiling, the use of NGS testing to identify targeted therapies and predict treatment outcomes is likely to become more widespread. Market players are anticipated to focus on developing comprehensive NGS panels for cancer profiling and pharmacogenomics to cater to the growing demand for personalized medicine solutions.
Furthermore, the COVID-19 pandemic has underscored the importance of NGS testing in infectious disease diagnostics and surveillance. The ability of NGS technology to rapidly sequence viral genomes and track the spread of infectious diseases has been instrumental in the global response to the pandemic. This has led to increased investments in NGS infrastructure and capabilities by governments and healthcare organizations worldwide, further fueling the growth of the clinical NGS testing market.
In conclusion, the global clinical next-generation sequencing testing market is poised for continued growth and innovation driven by factors such as increasing adoption in emerging**Market Players**
- 3billion, Inc.
- 10x Genomics
- 23andMe, Inc.
- Adaptive Biotechnologies
- Admera Health
- Agilent Technologies, Inc.
- ALCEN
- Almac Group
- AMARANTUS BIOSCIENCE HOLDINGS, INC.
- Ambry Genetics
- Aperiomics, Inc.
- ARUP Laboratories
- ASURAGEN, INC.
- Athena Diagnostics, Inc.
- Atreca, Inc.
- Base4
- Baylor Genetics
- BD
- Berry Gene
- BGI
- Bioarray S.L
- Biodesix
- Boreal Genomics Inc.
- Cambridge Epigenetix Limited
The global clinical next-generation sequencing (NGS) testing market is witnessing robust growth driven by various factors such as technological advancements in sequencing platforms, increasing demand for personalized medicine, and the rising prevalence of chronic diseases. Market players like Illumina, Thermo Fisher Scientific, and Oxford Nanopore Technologies are at the forefront of innovation, investing heavily in R&D to enhance the capabilities of NGS technology. The market is also fueled by the surge in NGS testing for infectious diseases, especially highlighted by the COVID-19 pandemic, which has led to increased investments in NGS infrastructure globally. Additionally, the shift towards precision medicine is propelling the demand for NGS testing in oncology and therapeutic areas, as healthcare providers recognize the value of
Explore Further Details about This Research Clinical Next-Generation Sequencing (NSG) Testing Market Report databridgemarketresearch.com/reports/global..
Browse More Reports:
Standalone Ultrasonic Cleaning Market
Isobutanol Market
Isostearic Acid Market
Cloud Access Security Broker Market
Seamless Pipes Market
Cryptocurrency Custody Software Market
Upstream Oil and Gas Water Management Services Market
Electro Diesel Locomotive Market
Butylated Triphenyl Phosphate Market
Automatic Fare Collection System Market
Latex-Saturated Paper Market
Integrated Marine Automation System Market
Keyboard, Video and Mouse (KVM) Switch Market
Closed System Transfer Devices Market
Fish Protein Concentrate Market
Opthalmology Surgical Microscopes Market
Roofing Chemicals Market
Data Bridge Market Research:
Today's trends are a great way to predict future events!
Data Bridge Market Research is a market research and consulting firm known for its innovative and unique approach, coupled with unparalleled resilience and integrated methods. We are committed to identifying prime market opportunities and delivering insightful information to help your business excel in the marketplace. Data Bridge provides customized solutions to complex business challenges, ensuring a seamless decision-making process. Founded in Pune in 2015, Data Bridge is the result of profound wisdom and extensive experience.
Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC: +653 1251 975
Email:- corporatesales@databridgemarketresearch.com
"